Biphenyl

Biphenyl

SCHEMBL396019

C1CCCCC1.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.75
MAPK1 P28482 2/20 0.50
TAAR1 Q96RJ0 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
NOTUM Q6P988 1/20 0.50
MMP3 P08254 1/20 0.50
BCL2L1 Q07817 1/20 0.50
SLC6A4 P31645 2/20 0.45
ATM Q13315 1/20 0.45
SLC22A2 O15244 1/20 0.45
SLC22A1 O15245 1/20 0.45
SLC22A3 O75751 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
MAOA P21397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL28699441 1.00 ALDH1A1 (0.75) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL28187064 1.00 ALDH1A1 (0.75) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL28611575 1.00 ALDH1A1 (0.75) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL27392926 1.00 ALDH1A1 (0.75) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL4073380 1.00 ALDH1A1 (0.75) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL27335593 0.96 ALDH1A1 (0.69) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL28440345 0.89 ALDH1A1 (0.60) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL164 0.87 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
Biphenyl SCHEMBL1358618 0.87 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4
SCHEMBL30108088 0.87 ALDH1A1 (1.00) ALDH1A1MAPK1TAAR1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116367571-A Electroluminescent device, method of manufacturing the same, display apparatus including the same, and layered structure 三星电子株式会社 2023-06-30 CN claimed
US-20230209995-A1 ELECTROLUMINESCENT DEVICE, PRODUCTION METHOD THEREOF, AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 US claimed
EP-4203648-A1 ELECTROLUMINESCENT DEVICE, PRODUCTION METHOD THEREOF, AND DISPLAY DEVICE INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2023-06-28 EP claimed
US-7700242-B2 Type of mixed additives and electrolyte for lithium-ion secondary batteries using such mixed additives BYD COMPANY LIMITED (CN) 2010-04-20 US claimed
US-20080286646-A1 Electrolytes for Lithium Ion Batteries and Their Fabrication Methods BYD COMPANY LIMITED (CN) 2008-11-20 US claimed
CN-101309753-A Carbonylation of ethylenically unsaturated compounds LUCITE INT UK LTD (GB) 2008-11-19 CN claimed
WO-2007059707-A1 ELECTROLYTES FOR LITHIUM ION BATTERIES AND THEIR FABRICATION METHODS BYD COMPANY LIMITED (CN) 2007-05-31 WO claimed
US-20070117012-A1 Electrolytes for lithium ion batteries and their fabrication methods BYD COMPANY LIMITED 2007-05-24 US claimed
US-20070105021-A1 Type of mixed additives and electrolyte for lithium-ion secondary batteries using such mixed additives BYD COMPANY LIMITED 2007-05-10 US claimed
CN-1204649-C Nonaqueous electrolyte solution and nonaqueous electrolyte solution secondary battery using the same MITSUBISHI CHEM CORP (JP) 2005-06-01 CN claimed
CN-1465115-A Nonaqueous electrolyte solution and nonaqueous electrolyte solution secondary battery using the same MITSUBISHI CHEM CORP (JP) 2003-12-31 CN claimed
EP-0037902-B1 LIQUID CRYSTAL DISPLAY ELEMENT KABUSHIKI KAISHA TOSHIBA (JP) 1986-06-18 EP claimed
EP-0037902-A1 Liquid crystal display element KABUSHIKI KAISHA TOSHIBA (JP) 1981-10-21 EP claimed
JP-58065782-A None JP disclosed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
US-20250260063-A1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY DAIKIN INDUSTRIES, LTD. (JP) 2025-08-14 US disclosed
US-4278327-A Liquid crystal matrices SPERRY CORPORATION (US) 1981-07-14 US disclosed
EP-0029737-A1 Electro-optical switching devices SPERRY CORPORATION (US) 1981-06-03 EP disclosed
US-4236150-A Liquid crystal display system MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1980-11-25 US disclosed
US-4228030-A Liquid crystal compositions GENERAL ELECTRIC COMPANY (US) 1980-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same ASH2L, OLA1, ODC1 ALDH1A1 1584/4885MAPK1 405/4885TAAR1 2275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.